Neural tissue damage presents substantial challenges within regenerative medicine, whether arising from acute trauma, chronic compression, or progressive degeneration. The nervous system’s limited inherent capacity for self-repair often results in lasting functional impairments that resist conventional therapeutic approaches. Emerging research on BPC-157, a synthetically stable pentadecapeptide derived from gastric protective proteins, has illuminated compelling pathways